Tally Surgical has filed a notice of an exempt offering of securities to raise $7,189,998.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Tally Surgical is raising up to $7,189,998.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brian Stewart played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Tally Surgical
Tally Surgical empowers hospitals to improve their patient outcomes, empower and protect their staff and realize significant cost savings by eliminating the most common adverse event in surgery retained surgical sponges. Our product offering, Tally, utilizes a proprietary RFID technology that simplifies and speeds an accurate counting process and unlike any other retained sponge prevention solution can accurately guide users to any missing sponges. We are industry veterans who pioneered the first generation of retained sponge prevention products. Hospitals and clinicians told us what they wanted in a new, improved solution. We listened. We combined extensive voice of customer with our deep category and development experience, infused a new proprietary technology and Tally was created.
To learn more about Tally Surgical, visit http://www.tallysurgical.com/
Contact:
Brian Stewart, Chief Executive Officer
310-710-7839
https://www.linkedin.com/in/brianestewart1/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.